![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Medgenics(Regs) | LSE:MEDG | London | Ordinary Share | COM SHS USD0.0001 (REGS) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 302.50 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMMEDG TIDMMEDU
RNS Number : 3654P
Medgenics Inc
01 October 2013
Press Release 1 October 2013
Appointment of Nominated Adviser and Joint Broker
Medgenics, Inc. (NYSE MKT: MDGN and AIM: MEDU, MEDG) ("the Company"), developer of a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, today announces that Oriel Securities Limited has been appointed as the Company's nominated adviser and joint broker with immediate effect.
About Medgenics
Medgenics is developing and commercializing Biopump(TM), a proprietary tissue-based platform technology for the sustained production and delivery of therapeutic proteins using the patient's own tissue for the treatment of a range of chronic diseases including anemia, hepatitis, among others. For more information, please visit www.medgenics.com.
For further information, please contact:
Abchurch Communications Joanne Shears / Jamie Hooper / Harriet Rae harriet.rae@abchurch-group.com +44 207 398 7719 Oriel Securities (NOMAD & Joint Broker) Jonathan Senior / Giles Balleny +44 207 776 1200 SVS Securities plc (Joint Broker) Alex Brearley +44 207 638 5600
-Ends-
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCNKDDKOBDKOKK
1 Year Medgenics(Regs) Chart |
1 Month Medgenics(Regs) Chart |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions